PMC:7696151 / 42489-42700 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1193","span":{"begin":153,"end":156},"obj":"Chemical"}],"attributes":[{"id":"A1193","pred":"tao:has_database_id","subj":"1193","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ime to reach steady-state concentrations, then delays the therapeutic effects. The next-generation formulations allow modulating the pharmacokinetics of HCQ. Avoiding systemic absorption, then liver first-pass m"}

{"project":"LitCovid-sentences","denotations":[{"id":"T275","span":{"begin":79,"end":157},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ime to reach steady-state concentrations, then delays the therapeutic effects. The next-generation formulations allow modulating the pharmacokinetics of HCQ. Avoiding systemic absorption, then liver first-pass m"}